Thrombocytopenia With High C-reactive Protein in Myeloma Patients Treated With Proteasome Inhibitor and/or Immunomodulatory Drugs
Thrombocytopenia was associated with the activity of NDMM and predicted prognosis in NDMM. When combined with high CRP levels, thrombocytopenia serves as a new indicator of poor prognosis in these patients.
Authors
- Riku Nagao
- Kazuhito Suzuki (ORCID: https://orcid.org/0000-0002-0300-378X)
- Hideki Uryu (ORCID: https://orcid.org/0000-0002-1891-9838)
- Tadahiro Gunji
- Shingo Yano (ORCID: https://orcid.org/0000-0002-5895-5382)
- Kaichi Nishiwaki
- Takeshi Saito (ORCID: https://orcid.org/0000-0003-4517-2060)
- M. Kawashima
Institutions
- Jikei University School of Medicine (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2024-11-02
- DOI
- https://doi.org/10.21873/cdp.10384
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jikei University School of Medicine